Market Overview

Benzinga's Top #PreMarket Losers

Share:
Related
Sarepta Therapeutics Announces New England Journal of Medicine Publication of Phase I Clinical Data of Marburg Drug Candidate, AVI-7288, Supporting Safety of the PMOplus® platform
Short-Sellers Betting Against These Biotechs
Related HSOL
Wild Swings In Solar Short Interest
US Stock Futures Point To Lower Open Monday

Sarepta Therapeutics (NASDAQ: SRPT) dipped 48.69% to $18.76 in the pre-market session. Sarepta reported a non-GAAP net loss of $21.3 million, or $0.63 per share. Piper Jaffray downgraded the stock from Overweight to Underweight.

Hanwha SolarOne Co (NASDAQ: HSOL) shares dropped 14.43% to $4.33 in pre-market trading on Q3 results.

Hologic (NASDAQ: HOLX) shares fell 12.66% to $20.00 in the pre-market trading after the company issued downbeat outlook for fiscal 2014. Canaccord Genuity downgraded the stock from Buy to Hold.

JA Solar Holdings Co (NASDAQ: JASO) dipped 3.89% to $11.60. JA Solar's trailing-twelve-month ROE is -24.62%.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (HOLX + HSOL)

Get Benzinga's Newsletters